Genflow Biosciences Share Discussion Threads

[moneymunch] 05/1/2024 18:44

Lol....very funny and utter nonsense, this is all about Genflow developing a safe, ethical delivery system of a variant of the Sirt6 gene found in centenarians, which is hoped to improve healthspan and extend lifespan by a couple of decades or more to begin with...Sirt6 is thought to be the most potent and fundamental gene involved in multiple disease targets and Genflow's R&D confirm compelling data as they progress towards human clinical trials in NASH in 2025 and update progress on the status of their planned clinical trials in Werner Disease and also dogs ...successful clinical trial results on any of their targets would increase Genflow's m/c by many millions of dollars, and catapult Genflow into mid cap range Bio thereafter, as Eric promotes Sirt6's healthspan and longevity credentials to a long list of Major pharma's who would be prepared to pay many of millions of dollars to own little old Genflow...Can't wait!!! Gl :-)

[luckyabbeygale] 05/1/2024 16:54

By being a share holder in this. You then gain the right to be one of the first people on earth to have the special longevity treatment. I have heard they can make people live up to 1,000 years longer.

Another thing is if you are not a shareholder then you most likely will not be able to afford this. Investing £2,000 or more will enable you to afford this longevity treatment. As by then this share will be worth at least 100 times more.

The cost is estimated at something like £200,000 per person for when it first comes out.

[moneymunch] 05/1/2024 15:30

Pesky profit takers Lawson, which has pegged the share price back a tad, as seen in all the Biotech risers today, but still great timing to buy before expected news is released, which hopefully will see the share price sail past 2p, 3p and more and plenty to look forward to this year...Gla holders:-)

[kubera369] 05/1/2024 14:42

Totally agree to every word you have mentioned here Eric has always delivered and is a experienced businessman Look at the team at Genflow and the patents they have already in the bag.They are the only bio science company in Europe and the UK with first mover advantage and are working on multiple solutions regarding Sirt6 No other company has gone that far - not even Altos Labs where we heavy hitter investors like Jeff BezosThis is simply priced too low in regards to Mcap / share price compared to peers in the sector and Genflow are simply too far ahead of the game already Loads of news incoming in the hottest sector of this year and beyond - Longevity and Anti Ageing as more of the world is waking up by taking their own health in their hands via holistic solutions The people have lost faith and trust of big pharma and modern day G.Ps post Covid.Wake up and smell the coffee.Simply buy in and sit down and watch this little acorn sprout into a huge mountainess treeGood luck not that you need it here

[aberdeano] 05/1/2024 14:24

Well we know it’s gonna be good news. We know what’s happening with the grants and how the pipeline is looking for this year then on into human trials hopefully early 25. The next update will be super positive. I can’t really think of what “bad” could come at this stage? Not getting grants/funding? Nah it’s in the bag! Anyone who jumped in today won’t regret it.

[babbler] 05/1/2024 13:59

The news is due. It will come. Overdue now. Could be good could be bad. Good it's back to 2 plus. Bad... Game over. Place your bets.

[lawson27] 05/1/2024 13:08

moneymunch......"Great timing Lawson"
Now looking a tad premature, FOMO :-(

[moneymunch] 05/1/2024 11:28

Looks like UK Biotech is hot hot hot this year and Genflow's tiny market cap looks extremely attractive commensurate to near term news and exciting prospects and potential going forward, in run up to human trials 2025!!! Gla :-)

[moneymunch] 05/1/2024 10:12

Rene up on invivo results etc, and looking good along with very positive sentiment on UK Biotech....Genflow are expecting imminent news on 4 x invivo Final Results. Gl :-)


Genflow

28/9/23

The Company continues to maintain a secure financial position and has sufficient cash reserves until March 2025. This is inclusive of grant funding which has been approved at the time of reporting and is due to be received in the coming months. The Company continues to seek further non-dilutive research grants which management will use to expedite specific phases of planned research and development.

......

The Company is conducting in-vivo evaluations of its centenarian SIRT6 gene therapy in four different NASH mice models in conjunction with four leading partners in the field: The University of Liverpool, UK, The University of Rochester, US, the International Clinical Research Center (FNUSA-ICRC) , Czech Republic and Physiogenex, France.

These studies have been wide reaching and have included the analysation of over 700 mice, with the intention of understanding the efficacy and safety of the Company's drug candidate in animal models with NASH and has generated essential information in preparation for clinical trials in humans. Final reports are expected by the end of 2023.

[tomavery19] 05/1/2024 09:43

Rene guys about to go vertical

[moneymunch] 05/1/2024 09:42

Great timing Lawson, I reckon...a flow of positive news could see this multi-bag quite easily...Genflow is all set for a stellar year ahead imho. Gl :')

[lawson27] 05/1/2024 09:36

Joined you for a few here @1.8, looks an interesting play, GLA

[moneymunch] 05/1/2024 09:30

Looking good and strong with news expected soon, which could add significant value. Gla holders :-)

[moneymunch] 05/1/2024 06:55

GenFlow Biosciences

1,386 followers

13h

Investing in GenFlow Biosciences (LSE: GENF)(OTCQB: GENFF) offers a unique opportunity to support pioneering work in the longevity field. Our company focuses on developing novel therapeutics that target the aging process, including our lead compound GF-1002, which is based on a centenarian variant of the SIRT6 gene. This innovative approach aims to extend both healthspan and lifespan, addressing the global challenge of aging and its associated health and economic impacts.

Learn more here:

#GENF #longevity #healthspan #SIRT6

[pie chart] 04/1/2024 16:51

So glad I have been patient and still heavily invested. This is what we have all been waiting for. Hopefully the start of a full recovery! GLA.

[moneymunch] 04/1/2024 16:44

Yes indeed, and now eagerly await a flow of good news from Eric for full investor focus and market interest to add significant value...massive upside potential from this current lowly bargain low...Gl :-)

[kubera369] 04/1/2024 16:38

It's about time this hidden gem is being talked about and I truly believe this year will be Big !!! Buyout also likely at any given time Crazy low Mcap compared to peers and we are the only longevity based company in the UK and Europe working on Sirt6Bring on the Re-Rate !!!

[kubera369] 04/1/2024 16:30

RE: Potential InvestorsSome decent articles popping up on Longevity, with Phil Newman noting family offices have a particular interest in the sector.The below article released yesterday also notes:"In the third quarter of 2023, the US contributed to 65% of all deals in the longevity sector, a report revealed, but Europe is getting involved as well. France and Switzerland made up 23% of total deals, with the UK at 5%."hTTps://sifted.eu/articles/new-year-longer-life-what-longevity-has-to-offer-in-2024I'm certainly glad to be invested

[moneymunch] 04/1/2024 16:25

GenFlow Biosciences

1,380 followers

3m

GenFlow Biosciences (LSE: GENF) (OTCQB: GENFF) is thrilled to be named "a firm to watch" by the The Guardian today.

As clinical trials for patients suffering from NASH get underway in 2025, we are very excited for 2024 and beyond.


Read the article here: #GENF #longevity #healthspan #SIRT6 #smallcaps #companytowatch

[moneymunch] 04/1/2024 15:20

Get UP there!!! " A Bright New Year " ahead, with any Luck. In Eric we trust!!! ;-)

[pie chart] 04/1/2024 14:44

Yes. Followed by a response re: News early Jan!!

[kubera369] 04/1/2024 14:38

Has anyone read the gospel on Linked in about GenGlow Looks like some ear bashing towards Eric and the paltry share price we are sat upon.This share is bombed out and is an incredible opportunity to buy in low before it rockets and we all know how fast it moves.Last move to it well above 5p and it's just 1.5p to buy

[kubera369] 04/1/2024 14:31

Sellers will regret selling as news on the horizon now Crazy world as folk must be desperate for cash Wait another month and take double or more in profits.